Nedbank CIB Guides Ethos in Vertice MedTech Exit to Amethis-Led Consortium

The healthcare sector in Africa is garnering unprecedented attention from investors, with the Corporate Finance team at Nedbank Corporate and Investment Banking (CIB) playing a pivotal role in this momentum.

Recently, the investment bank provided advisory services to Ethos during the strategic sale of its stake in Vertice MedTech, a move that attracted global buyer interest and highlights the growing allure of healthcare assets in emerging markets.

This transaction is part of Ethos Fund VI’s ongoing realization strategy, representing a significant achievement for Ethos and showcasing Nedbank CIB’s advisory expertise.

Vertice MedTech stands out as a premier independent distributor of specialized medical devices and mobile healthcare solutions.

The company is vital to healthcare delivery in South Africa and other African regions, facilitating over 7,000 surgeries each month and supporting national health initiatives through mobile medical units.

Its offerings include advanced medical devices, software service, and health IT consulting—key components for enhancing healthcare accessibility and outcomes in a region experiencing a sharp increase in demand for modern medical solutions.

Additionally, the business is expanding its technological footprint in Europe, reflecting the global dynamics of contemporary healthcare enterprises.

As corporate advisor to both Ethos and Vertice MedTech, Nedbank CIB successfully navigated a competitive process that garnered significant interest from international buyers.

This outcome underscores the bank’s proficiency in executing intricate private equity exits and cross-border deals, particularly in sectors that necessitate substantial technical expertise and strategic acumen.

“Healthcare remains a rapidly developing and value-adding investment sector,” states Avinash Kalkapersad, investment banking originator at Nedbank CIB.

“Our participation in this transaction highlights our capacity to provide strategic results for clients in sectors that truly matter.”

Michael Jensen, a partner at Ethos, shares: “After successfully growing Vertice MedTech since its acquisition in 2018, we decided it was the right moment to exit in alignment with our broader asset realization strategy.

“Nedbank CIB’s expert guidance ensured a fruitful transaction.”

This deal arrives as healthcare investments in Africa are surging, fueled by demographic changes, an increase in demand for specialized services, and the necessity for technology-driven solutions.

For investors, this sector offers a compelling blend of financial returns and social impact, positioning it as one of the most attractive realms for capital allocation in emerging markets.

By facilitating this deal, Nedbank CIB has proven its capability to secure global buyers for strategic African assets—a competency that is becoming increasingly crucial as cross-border transactions grow more competitive.

The bank is poised to be a significant player in the healthcare sector, which continues to flourish due to aging populations, technological advancements, rising chronic disease prevalence, and the expansion of the global middle class.

For Nedbank CIB, this transaction signifies more than just a deal. It exemplifies the firm’s ability to merge sector expertise with strategic insight, delivering solutions that provide value for clients and communities alike.

As healthcare investments accelerate throughout Africa, Nedbank CIB remains at the forefront, shaping the future of advisory excellence in the sectors that are most significant.

Healthcare represents more than an investment opportunity; it is a field that profoundly affects lives. Transactions like this enable companies such as Vertice MedTech to continue providing essential services, driving innovation, and enhancing health outcomes across Africa.

For investors and stakeholders, these deals embody the intersection of financial performance and social impact—a domain in which Nedbank CIB is dedicated to leading.

Brought to you by Nedbank CIB.

Moneyweb does not endorse any product or service being advertised in sponsored articles on our platform.